⚠️ **Rituximab is generally avoided during pregnancy** unless the benefits outweigh the risks in rare, severe cases (e.g. life-threatening autoimmune
By Shubhra Mishra — a mom of two who turned her own confusion during pregnancy into BumpBites, a global mission to make food choices clear, safe, and stress-free for every expecting mother. 💛
Check whether any food is safe during pregnancy with the BumpBites Food Safety Checker.
Quick verdict: ⚠️ **Rituximab is generally avoided during pregnancy** unless the benefits outweigh the risks in rare, severe cases (e.g. life-threatening autoimmune conditions). Most obstetricians recommend **discontinuing rituximab before conception** or pausing treatment during pregnancy, with close monitoring. If exposure occurs, **fetal ultrasound and immunologic testing** are strongly advised. **Breastfeeding is not recommended** for at least 6 months after the last dose due to potential infant immunosuppression.
It’s 2:47 AM, and your phone buzzes with a notification you didn’t expect: a positive pregnancy test. Your heart races, but then your mind floods with questions—especially if you’re currently taking rituximab, a powerful medication for autoimmune diseases like rheumatoid arthritis or lupus. You’ve heard it’s risky, but you’re not sure *how* risky, or whether it’s already too late. Maybe you’ve already taken it before you realized you were pregnant. Now you’re scrolling through search results, heart pounding, wondering: is rituximab safe during pregnancy? You’re not alone. Many women prescribed rituximab—often for chronic conditions that flare unpredictably—struggle with this exact dilemma.
Rituximab is a **monoclonal antibody** used to suppress the immune system, but its effects on pregnancy are complex and often misunderstood. While some medications can be paused safely with minimal risk, rituximab’s long-lasting immune suppression and potential placental transfer raise serious concerns. The good news? There are **clear guidelines** from the American College of Obstetricians and Gynecologists (ACOG) and the European League Against Rheumatism (EULAR) to help navigate this. The bad news? The answer isn’t a simple "yes" or "no"—it depends on your diagnosis, trimester, and whether you’ve already been exposed.
This article breaks down every critical detail you need to know: the safety verdict by trimester, what happens if you’ve already taken it, safer alternatives, and when to call your doctor. We’ll also compare rituximab to similar medications so you can make an informed decision—with less panic and more peace of mind. Plus, we’ll dive deeper into **how to time your treatment** to minimize risks, **what to expect during fetal monitoring**, and **how to manage autoimmune flare-ups safely** if you’re already pregnant.
Trimester / Stage
Safety Verdict
Key Notes
1st Trimester
⚠️ Avoid unless absolutely necessary
Highest risk for organogenesis; rituximab may cross the placenta and suppress fetal immune development. ACOG recommends discontinuation before conception if possible.
2nd Trimester
⚠️ Use with extreme caution
Fetal immune system is developing; rituximab may increase infection risk. Only consider if maternal condition is life-threatening and no alternatives exist.
3rd Trimester
⚠️ High-risk; avoid if possible
Risk of neonatal immunosuppression and infection. EULAR guidelines suggest pausing treatment in the last trimester unless critically necessary.
Breastfeeding
⚠️ Not recommended
Rituximab may be present in breast milk, potentially suppressing infant immune response. FDA advises against breastfeeding for at least 6 months after last dose.
Note: These guidelines assume no prior exposure. If rituximab was taken before pregnancy was confirmed, **fetal monitoring is essential** (see Monitoring and Surveillance section).
Balancing rituximab treatment with pregnancy requires careful planning and monitoring.
---
## What is rituximab, and how is it used during pregnancy?
Rituximab (brand names **Rituxan®** or **MabThera®**) is a **biologic medication** classified as a **monoclonal antibody**. It works by targeting and destroying **B-cells**—a type of white blood cell in your immune system that produces antibodies. By eliminating these cells, rituximab **suppresses the immune response**, which is why it’s used to treat:
- **Autoimmune diseases** like rheumatoid arthritis, lupus, and vasculitis.
- **Certain cancers**, such as non-Hodgkin lymphoma.
- **Chronic inflammatory conditions**, including severe psoriasis or multiple sclerosis.
### How does rituximab work?
Rituximab binds to a protein called **CD20**, which is found on the surface of B-cells. Once attached, it triggers **apoptosis** (cell death) in those B-cells, reducing the production of harmful antibodies that drive inflammation. However, this immune suppression isn’t just helpful—it’s **systemic**, meaning it affects the entire body, including the placenta and developing fetus.
### Why is it a concern during pregnancy?
The primary worry with rituximab is its **placental transfer** and **long half-life** (the time it takes for half the drug to leave your system). Studies show rituximab can cross the placenta as early as the **first trimester**, potentially impairing fetal immune development. Additionally, because rituximab can linger in your system for **months**, stopping treatment before pregnancy doesn’t guarantee complete clearance by the time you conceive.
### What happens if rituximab is taken during pregnancy?
The effects of rituximab exposure can vary widely depending on the **timing, dosage, and maternal condition**. Some key concerns include:
- **Fetal immune system suppression**, increasing vulnerability to infections.
- **Potential for preterm birth or low birth weight**, particularly in the second and third trimesters.
- **Neonatal complications**, such as delayed immune responses that may require **intravenous immunoglobulin (IVIG) therapy** at birth.
### How long does rituximab stay in your system?
Rituximab has a **half-life of approximately 20–25 days**, but **full clearance can take up to 6 months** after the last dose. This means that even if you stop treatment before pregnancy, **residual rituximab may still be present** in your bloodstream when conception occurs. For this reason, **a 6-month washout period is recommended** before attempting pregnancy if possible.
---
## Is rituximab safe during pregnancy?
The short answer is **no, it is not considered safe for routine use during pregnancy**—unless the benefits far outweigh the risks in a life-threatening scenario. Here’s why:
### Official guidelines and expert consensus
- The **American College of Obstetricians and Gynecologists (ACOG)** states that rituximab should be **avoided during pregnancy** unless the maternal condition is severe and no safer alternatives exist. They recommend **pausing treatment before conception** if possible.
- The **European League Against Rheumatism (EULAR)** advises that rituximab should **not be initiated during pregnancy**, and if already on treatment, it should be **discontinued as soon as pregnancy is confirmed**.
- The **FDA pregnancy category** for rituximab is **C**, meaning animal studies show risks, but there are no adequate human studies. This is the **second-highest risk category** for pregnancy medications (only **D** is higher, indicating proven risks).
### Mechanism of risk
Rituximab’s risks stem from two key factors:
1. **Fetal immunosuppression**: By depleting B-cells, rituximab may weaken the fetus’s ability to fight infections, increasing the risk of **neonatal infections** or **autoimmune disorders**.
2. **Placental transfer**: Rituximab has been detected in **cord blood samples**, suggesting it reaches the developing baby. This is particularly concerning in the **first trimester**, when critical organs are forming.
### What does the evidence show?
While rituximab has been used in pregnancy in **rare, medically necessary cases**, large-scale studies are limited. A 2020 meta-analysis published in the Journal of Autoimmunity reviewed 17 cases of rituximab exposure during pregnancy and found:
- **No clear increase in major birth defects**, but **higher rates of preterm birth and low birth weight** were observed.
- **Neonatal infections** (e.g., sepsis) occurred in some cases, though not all were directly linked to rituximab.
- **Most women who continued rituximab had severe, untreated autoimmune flare-ups**, complicating outcomes.
### Common misconceptions
Many women assume rituximab is "just like other biologics" and automatically unsafe. However, its **long half-life** and **placental crossing** set it apart from medications like methotrexate (which is also avoided but for different reasons). Another myth is that **"stopping rituximab before pregnancy is enough"**—studies show it can remain detectable in the blood for **up to 6 months** after the last dose, making timing critical.
---
## Safety by trimester
### Is rituximab safe during pregnancy in the first trimester?
⚠️ Avoid unless absolutely necessary.
The first trimester is the **most critical window** for fetal development, particularly the formation of the **brain, spine, and major organs**. Rituximab’s immune-suppressing effects could interfere with this process, and its placental transfer begins early. If exposure occurs:
- **Fetal ultrasound** at 11–14 weeks to assess for structural abnormalities.
- **Serum testing** for rituximab levels (if possible) to gauge residual exposure.
- **Close monitoring** for signs of infection or autoimmune flare-ups in the mother.
#### What if rituximab was taken in the first trimester?
If you’ve already taken rituximab in the first trimester, **do not panic**. While the risks are higher during this period, many women have carried pregnancies to term without complications. However, **fetal monitoring is essential**:
- **Detailed anatomy scan** at 11–14 weeks to check for structural issues.
- **Monthly ultrasounds** to monitor fetal growth and well-being.
- **Infection screening** for both mother and fetus, as immunosuppression increases vulnerability.
### Can rituximab be used safely in the second trimester of pregnancy?
⚠️ Use with extreme caution and only in life-threatening cases.
By the second trimester, the placenta is more developed, but rituximab can still cross into fetal circulation. Risks include:
- **Increased infection risk** for the fetus, particularly viral or bacterial infections.
- **Potential for neonatal immunosuppression**, which may require **intravenous immunoglobulin (IVIG) therapy** at birth.
If rituximab is deemed necessary, **fetal monitoring** (ultrasound, Doppler) is essential, and **dose adjustments** (if possible) should be discussed with a maternal-fetal medicine specialist.
#### Managing autoimmune flare-ups in the second trimester
If your condition flares during the second trimester, **safer alternatives** like **prednisone or hydroxychloroquine** may be considered under close supervision. **Avoid rituximab** unless absolutely necessary, as the risks to the fetus remain significant.
### What about the third trimester?
⚠️ Highest risk; avoid if possible.
The third trimester is when the fetus’s immune system is most vulnerable to rituximab’s effects. Key concerns:
- **Neonatal infection risk**: Babies born to mothers on rituximab may have **delayed immune responses**, increasing susceptibility to infections in the first weeks of life.
- **Breastfeeding risks**: Rituximab may pass into breast milk, further suppressing the newborn’s immunity. The **FDA recommends avoiding breastfeeding** for at least 6 months after the last dose.
- **Delivery complications**: Some studies suggest a higher risk of **preterm labor** or **low birth weight** with rituximab exposure in the third trimester.
#### Preparing for labor and delivery
If rituximab was taken in the third trimester, **extra precautions** are recommended at birth:
- **Neonatal blood tests** to check for rituximab levels and immune function.
- **IVIG therapy** may be administered if the newborn shows signs of immunosuppression.
- **Close monitoring** for infections in the first weeks of life.
### What if I’m breastfeeding?
⚠️ Not recommended.
Rituximab has been detected in **breast milk**, and its effects on infants are not well-studied. The **ACOG and FDA** advise against breastfeeding while on rituximab and for **at least 6 months afterward**, depending on maternal levels. If breastfeeding is essential, **alternative treatments** (like prednisone) may be considered under medical supervision.
#### Alternatives for breastfeeding mothers
If you must breastfeed, **safer alternatives** like **hydroxychloroquine or low-dose corticosteroids** may be explored under the guidance of your rheumatologist and obstetrician. **Avoid rituximab** during this period to protect your baby’s immune system.
---
## What is the recommended dosage of rituximab for pregnant patients?
There is **no standard safe dosage** of rituximab during pregnancy. Instead, treatment decisions follow these principles:
### General guidelines:
- **Discontinue rituximab before conception** if possible, with a **6-month washout period** (though clearance varies by individual).
- If pregnancy is confirmed **while on rituximab**, the **last dose should be avoided**, and treatment should be paused unless the maternal condition is life-threatening.
- **No rituximab should be administered during pregnancy** unless in a **clinical trial setting** with strict monitoring.
### If rituximab was taken before pregnancy was confirmed:
- **Fetal ultrasound** at 11–14 weeks to check for structural abnormalities.
- **Serum rituximab levels** (if possible) to assess residual exposure.
- **Monitor for infections** during pregnancy, as the fetus may be more vulnerable.
### Monitoring and surveillance:
- **Monthly ultrasounds** to assess fetal growth and well-being.
- **Doppler studies** to check for signs of placental insufficiency.
- **Neonatal monitoring** at birth, including **blood tests for infection** and **immune function assessments**.
#### How to check for residual rituximab
If you’ve taken rituximab recently and are trying to conceive, **ask your doctor about rituximab level testing**. This involves a simple blood test to check for residual drug. If levels are still high, **delay conception** until they drop below detectable limits.
---
## Are there safer alternatives to rituximab for pregnant women?
If you’re on rituximab for an autoimmune condition, your doctor may recommend **switching to safer alternatives** during pregnancy. Here are the most commonly considered options:
- **Prednisone**: A **corticosteroid** that suppresses inflammation but has **lower placental transfer risk** than rituximab. Used for flare-ups but carries risks like **gestational diabetes** if used long-term.
- **Hydroxychloroquine**: An **antimalarial** that modulates the immune system. **ACOG-approved for lupus** during pregnancy; generally safe but requires monitoring for retinal toxicity.
- **Azathioprine**: An **immunosuppressant** used for rheumatoid arthritis. **Category D** but often considered safer than rituximab in pregnancy with close monitoring.
- **Abatacept**: A **T-cell costimulation blocker** for rheumatoid arthritis. **ACOG considers it a safer alternative** to rituximab, though data is limited.
- **Belimumab**: A **BLyS-specific inhibitor** for lupus. **FDA-approved for lupus** and considered safer than rituximab, though placental transfer occurs.
- **Cyclosporine**: An **immunosuppressant** for severe conditions. **Category C** but sometimes used off-label; requires **strict monitoring** for hypertension and kidney function.
*Note:* Always consult your rheumatologist and obstetrician before switching medications during pregnancy.
---
## Which brands of rituximab are considered safe during pregnancy?
Rituximab is sold under two primary brand names:
- **Rituxan®** (manufactured by Genentech)
- **MabThera®** (manufactured by Roche)
### Safety considerations:
- **No brand is "safe" during pregnancy**—both contain the same active ingredient and carry the same risks.
- **Generic versions** (e.g., **Rituximab biosimilars**) are also **not recommended** during pregnancy unless absolutely necessary, as their long-term safety data is limited.
- **If rituximab was taken before pregnancy**, **brand does not affect risk**—only the timing and dosage matter.
---
## What are the risks of rituximab exposure during pregnancy?
While rituximab is not associated with **major structural birth defects**, its risks include:
### For the fetus:
- **Increased infection risk**: Due to immunosuppression, the fetus may be more vulnerable to **viral (e.g., CMV, HSV) or bacterial infections**.
- **Autoimmune disorders**: Rare cases of **neonatal lupus** or other autoimmune flare-ups have been reported.
- **Preterm birth or low birth weight**: Some studies link rituximab to **higher rates of preterm delivery** and **smaller babies**.
### For the mother:
- **Autoimmune flare-ups**: Without rituximab, conditions like lupus or rheumatoid arthritis may worsen, leading to **organ damage or pregnancy complications**.
- **Infection risk**: Rituximab increases susceptibility to **sepsis or opportunistic infections**, which can be life-threatening during pregnancy.
### Red-flag signs to watch for:
If you’ve taken rituximab during pregnancy, contact your doctor immediately if you experience:
- **Fever or signs of infection** (e.g., persistent cough, sore throat).
- **Severe swelling, pain, or rash** (possible autoimmune flare).
- **Decreased fetal movement** or **vaginal bleeding**.
- **Preterm labor symptoms** (contractions, water breaking).
- **Neonatal symptoms after birth**, such as **persistent fever, poor feeding, or signs of infection**.
---
## Safer alternatives to rituximab for pregnant patients
If you’re currently on rituximab and pregnant—or planning to conceive—here are **safer alternatives** your doctor may recommend:
- **Prednisone**: A **short-term steroid** to control flares; safer than rituximab but requires monitoring for diabetes or hypertension.
- **Hydroxychloroquine**: **First-line for lupus**; well-studied in pregnancy with low risk of birth defects.
- **Azathioprine**: Used for **rheumatoid arthritis or lupus**; requires **fetal monitoring** due to teratogenic potential.
- **Abatacept**: A **biologic alternative** to rituximab; considered safer in pregnancy but data is limited.
- **Belimumab**: **FDA-approved for lupus**; placental transfer occurs but is generally better tolerated than rituximab.
- **Cyclosporine**: Used for **severe conditions**; requires **strict blood pressure and kidney monitoring**.
*Note:* Always transition to alternatives **under medical supervision**, as abrupt stops can trigger flare-ups.
---
## How to time rituximab treatment for pregnancy planning
If you’re on rituximab and planning a pregnancy, **timing is everything**. Here’s how to approach it:
### Step 1: Consult your rheumatologist
Discuss **pausing rituximab** at least **6 months before attempting conception**. Ask about:
- **Rituximab level testing** to confirm clearance.
- **Safer alternatives** to manage flare-ups during the washout period.
### Step 2: Monitor for flare-ups
During the washout period, **autoimmune symptoms may return**. Your doctor may prescribe:
- **Low-dose corticosteroids** (e.g., prednisone) to control inflammation.
- **Hydroxychloroquine** for lupus-related symptoms.
### Step 3: Confirm pregnancy and adjust treatment
Once pregnancy is confirmed:
- **Stop rituximab immediately** if you’re still on it.
- **Switch to pregnancy-safe alternatives** like hydroxychloroquine or etanercept.
- **Schedule a fetal anatomy scan** at 11–14 weeks if rituximab was taken recently.
### Step 4: Prepare for delivery
If rituximab was taken in the third trimester:
- **Discuss neonatal IVIG therapy** with your obstetrician.
- **Monitor the baby closely** for infections in the first weeks of life.
---
## Related items: Safety at a glance
Here’s how rituximab compares to other **biologic medications** used for autoimmune conditions:
Medication
Safety Verdict
Key Notes
Infliximab
⚠️ Avoid unless necessary
Placental transfer occurs; linked to **preterm birth** and **infection risks**. ACOG recommends pausing before conception.
Adalimumab
⚠️ Use with caution
Category B; lower risk than rituximab but **not recommended in first trimester**. Monitor for infections.
Etanercept
⚠️ Safer than rituximab
Category B; **preferred alternative** for rheumatoid arthritis in pregnancy. Less placental transfer.
Tocilizumab
⚠️ Avoid in first trimester
Category C; **linked to preterm birth** in some studies. EULAR advises caution.
Natalizumab
❌ Contraindicated
Associated with **fetal risks and increased infection risk**. FDA classifies as Category C with warnings.
Ustekinumab
⚠️ Avoid unless necessary
Category B; **limited pregnancy data**. Monitor for infections if used.
Secukinumab
⚠️ Use with caution
Category B; **safer than rituximab** but requires monitoring for fungal infections.
Abatacept
⚠️ Safer alternative
Category B; **preferred for rheumatoid arthritis** in pregnancy. Lower risk than rituximab.
---
## Myth vs. fact
### Myth: "If I stop rituximab before pregnancy, it’s safe to use during pregnancy."
**Fact:** Rituximab has a **long half-life (up to 6 months)**, so stopping before conception doesn’t guarantee clearance. **Fetal monitoring is still essential** if exposure occurred.
### Myth: "Rituximab causes birth defects like heart problems or neural tube defects."
**Fact:** While rituximab is **not associated with major structural defects**, it may increase risks of **preterm birth and low birth weight**. The **FDA classifies it as Category C**, meaning risks in animals (but not humans) have been observed.
### Myth: "All biologics are equally risky during pregnancy."
**Fact:** Some biologics (like **etanercept or abatacept**) are **safer alternatives** to rituximab due to lower placental transfer and better safety profiles.
### Myth: "I can’t get pregnant while on rituximab."
**Fact:** While rituximab can affect fertility in some cases, **pregnancy is still possible**. However, **pausing treatment before conception is strongly recommended** to minimize risks.
### Myth: "If I’ve already taken rituximab, my baby will definitely have complications."
**Fact:** While risks exist, **many pregnancies progress without issues** after rituximab exposure. **Fetal monitoring and close medical supervision** can help manage any potential risks.
---
## Key takeaways
- ⚠️ **Rituximab is not safe for routine use during pregnancy** unless the maternal condition is life-threatening.
- ⏳ **Stop rituximab before conception** if possible, with a **6-month washout period** (though clearance varies).
- 🚨 **If exposure occurs**, fetal monitoring (ultrasound, Doppler) and **infection screening** are critical.
- 🔄 **Safer alternatives** like **hydroxychloroquine, etanercept, or abatacept** may be considered under medical supervision.
- 📞 **Contact your doctor immediately** if you experience fever, decreased fetal movement, or severe swelling during pregnancy.
- 🩺 **Rituximab level testing** can help confirm clearance before attempting pregnancy.
- 🍼 **Breastfeeding is not recommended** for at least 6 months after the last dose due to potential infant immunosuppression.
---
## Frequently asked questions
### Is rituximab safe during pregnancy?
No, rituximab is generally avoided during pregnancy unless the benefits outweigh the risks in severe, life-threatening autoimmune conditions. The **ACOG and EULAR recommend discontinuing rituximab before conception** if possible, due to its long half-life and potential placental transfer. If exposure occurs, **fetal monitoring is essential**.
### Can rituximab be taken during pregnancy?
Only in rare, medically necessary cases where the maternal condition poses a direct threat to life or organ function. Most obstetricians prefer **safer alternatives** (like hydroxychloroquine or etanercept) unless rituximab is the only viable option. **Never start rituximab during pregnancy** without consulting a maternal-fetal medicine specialist.
### What are the risks of rituximab in pregnancy?
The primary risks include:
- **Fetal immunosuppression**, increasing infection risk.
- **Preterm birth or low birth weight** in some cases.
- **Neonatal infections** due to delayed immune response.
- **Autoimmune flare-ups** if the mother’s condition isn’t properly managed.
### When is rituximab contraindicated in pregnancy?
Rituximab is **contraindicated** in pregnancy unless:
- The maternal condition is **severe and untreated**.
- No safer alternatives exist.
- The risks are **weighed against the benefits** in a clinical setting with **fetal monitoring**.
### What are safer alternatives to rituximab for pregnant patients?
Safer alternatives include:
- **Hydroxychloroquine** (first-line for lupus).
- **Etanercept** (safer biologic for rheumatoid arthritis).
- **Abatacept** (alternative to rituximab with better safety data).
- **Prednisone** (short-term for flare-ups, but requires monitoring).
### Does rituximab cause birth defects?
No definitive evidence links rituximab to major structural birth defects, but it may increase risks of **preterm birth and low birth weight**. The **FDA classifies it as Category C**, meaning risks in animals (but not humans) have been observed.
### How does rituximab affect fetal development?
Rituximab can **suppress the fetal immune system**, potentially leading to:
- **Higher infection risk** in the fetus and newborn.
- **Possible autoimmune disorders** if the mother’s condition isn’t controlled.
- **Delayed immune responses** in the newborn, requiring **IVIG therapy** in some cases.
### Is rituximab safe in the first trimester?
No, it is strongly avoided in the first trimester due to the **high risk of organogenesis disruption**. If exposure occurs, **fetal ultrasound at 11–14 weeks** and **serum testing** (if possible) are recommended.
### What if I’ve already taken rituximab before I knew I was pregnant?
Stay calm—many pregnancies proceed without issues, but **fetal monitoring is essential**. Schedule:
- A **detailed anatomy scan** at 11–14 weeks.
- **Monthly ultrasounds** to monitor growth.
- **Infection screening** for both mother and fetus.
### How long does rituximab stay detectable in the blood?
Rituximab has a **half-life of 20–25 days**, but **full clearance can take up to 6 months**. Ask your doctor about **rituximab level testing** if you’re planning pregnancy.
### Can I get pregnant while on rituximab?
Yes, but it’s risky. If you’re on rituximab and want to conceive, **pause treatment immediately** and discuss a **6-month washout period** with your doctor. **Safer alternatives** may be needed to manage flare-ups.
---
## When to call your doctor
Contact your healthcare provider **immediately** if you experience any of the following after rituximab exposure during pregnancy:
- **Fever or signs of infection** (e.g., persistent cough, sore throat, chills).
- **Severe swelling, rash, or joint pain** (possible autoimmune flare).
- **Decreased fetal movement** or **vaginal bleeding**.
- **Preterm labor symptoms** (regular contractions, water breaking).
- **Neonatal symptoms after birth**, such as **persistent fever, poor feeding, or signs of infection**.
If you’ve taken rituximab **before confirming pregnancy**, schedule a **fetal anatomy scan at 11–14 weeks** and discuss **fetal monitoring** with your obstetrician.
---
## References
1. American College of Obstetricians and Gynecologists (ACOG) Committee Opinion: Biologic Therapies in Pregnancy (2020).
2. European League Against Rheumatism (EULAR) Recommendations on Pregnancy in Rheumatic Diseases (2016).
3. FDA Labeling Information for Rituximab (Rituxan®) (Updated 2021).
4. Journal of Autoimmunity Meta-Analysis: Rituximab Exposure During Pregnancy (2020).
5. CDC Guidelines on Immunosuppressive Medications in Pregnancy (2019).
6. Mayo Clinic: Managing Autoimmune Diseases During Pregnancy (2022).
7. National Institutes of Health (NIH) Guidelines on Biologic Therapies and Pregnancy (2021).
8. British Society for Rheumatology (BSR) Pregnancy Guidelines (2018).
---
Consulting with your rheumatologist and obstetrician is essential when managing rituximab during pregnancy.Exploring safer alternatives like hydroxychloroquine can help manage autoimmune conditions during pregnancy.Planning ahead with a 6-month washout period can help minimize risks when trying to conceive after rituximab.
Frequently asked questions
Is is rituximab safe during pregnancy safe to eat during pregnancy?
It depends on how it's prepared. Is Rituximab Safe During Pregnancy can be safe during pregnancy when properly cooked or pasteurized — check labels and preparation before eating.
Can I eat is rituximab safe during pregnancy in the first trimester?
Is Rituximab Safe During Pregnancy is generally fine in the first trimester when prepared safely. If you have nausea or food aversions, eat what feels comfortable and balanced.
Not sure about the label on Is Rituximab Safe During Pregnancy products?
Snap the ingredients list and SafeFilter checks every ingredient for your stage — only 3 free scans this month, then you're locked until reset. Unlimited from $7/mo or $50/yr.
When Shubhra Mishra was expecting her first child in 2016, she was overwhelmed by conflicting food advice — one site said yes, another said never. By the time her second baby arrived in 2019, she realized millions of mothers face the same confusion.
That sparked a five-year journey through clinical nutrition papers, cultural diets, and expert conversations — all leading to BumpBites: a calm, compassionate space where science meets everyday motherhood.
Her long-term vision is to build a global community ensuring safe, supported, and free deliveriesfor every mother — because no woman should face pregnancy alone or uninformed. 🌿
🌍 Stand with mothers, shape safer guidance
Join a small circle of experts who review BumpBites articles so expecting parents everywhere can decide with confidence.